Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Eli Lilly
Ownership Structure: publicly traded (ticker symbol LLY)
Headquartered in: Indiana
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
| State/Local | $292,469,138 | 70 |
| Federal (grants and allocated tax credits) | $3,109,068 | 4 |
| TOTAL | $295,578,206 | 74 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards: Earliest year of data: 1999. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2011.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
For an overview of this company's accountability track record, read its Corporate Rap Sheet
here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
| Indiana | $214,500,000 | 2 |
| New Jersey | $36,377,636 | 5 |
| Pennsylvania | $12,852,680 | 15 |
| Iowa | $11,481,729 | 5 |
| North Carolina | $11,311,364 | 13 |
| All other | $5,945,729 | 30 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Company  . | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
| NOVASITE PHARMACEUTICALS INC | United States | federal | 2005 | $1,133,906 | | federal grant |
| NOVASITE PHARMACEUTICALS INC | United States | federal | 2004 | $944,279 | | federal grant |
| Novartis Animal Health US, Inc. | North Carolina | state | 2012 | $98,209 | | tax credit/rebate |
| Novartis Animal Health US, Inc. | North Carolina | state | 2015 | $885,684 | | tax credit/rebate |
| Novartis Animal Health US, Inc. | North Carolina | state | 2010 | $62,965 | | tax credit/rebate |
| ImClone Systems LLC | New York | state | 2012 | $901,984 | | enterprise zone |
| ImClone Systems Corporation | New Jersey | state | 1999 | $625,260 | | grant |
| ImClone Systems Corporation | New Jersey | state | 2001 | $2,755,200 | | grant |
| ImClone Systems Corporation | New Jersey | state | 2008 | $32,363,676 | | grant |
| ImClone Systems Corporation | New York | state | 2011 | $574,259 | | enterprise zone |
| ImClone Systems | New Jersey | state | 2010 | $350,000 | | tax credit/rebate |
| ImClone Systems | New Jersey | state | 2010 | $283,500 | | Tax credit/rebate |
| ICOS CORPORATION | Washington | state | 2006 | $293,138 | | tax credit/rebate |
| ICOS CORPORATION | Washington | state | 2007 | $36,309 | | tax credit/rebate |
| ICOS CORPORATION | Washington | state | 2006 | $72,042 | | tax credit/rebate |
| ICOS CORPORATION | Washington | state | 2007 | $1,375 | | tax credit/rebate |
| I C O S CORP | Washington | state | 2004 | $263,847 | | tax credit/rebate |
| I C O S CORP | Washington | state | 2005 | $178,127 | | tax credit/rebate |
| I C O S CORP | Washington | state | 2004 | $22,005 | | tax credit/rebate |
| Eli Lilly dba Elanco Animal Health | Indiana | state | 2013 | $500,000 | | grant |
| Eli Lilly And Company | Pennsylvania | state | 2010 | $1,128,200 | | tax credit/rebate |
| Eli Lilly and Company | Pennsylvania | state | 2011 | $2,114,575 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2011 | $220,883 | | tax credit/rebate |
| Eli Lilly and Company | Pennsylvania | state | 2012 | $3,552,766 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2010 | $20,997 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2011 | $27,537 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2009 | $191,686 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2008 | $64,386 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2012 | $39,722 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2004 | $34,995 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2007 | $32,430 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2005 | $19,898 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2014 | $39,722 | | tax credit/rebate |
| Eli Lilly and Company | Pennsylvania | state | 2013 | $5,019,493 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2013 | $338,906 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2013 | $44,364 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2013 | $338,906 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2015 | $127,208 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2015 | $416,189 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2015 | $210,178 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2016 | $36,029 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2017 | $45,454 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2018 | $125,820 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2019 | $172,893 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2017 | $51,414 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2018 | $24,721 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2019 | $12,415 | | tax credit/rebate |
| Eli Lilly and Company | North Carolina | state | 2020 | $8,689,500 | | grant |
| Eli Lilly and Company | Maryland | state | 2020 | $92,287 | | tax credit/rebate |
| Eli Lilly and Company | Maryland | state | 2021 | $41,307 | | tax credit/rebate |
| ELI LILLY & COMPANY | Missouri | state | 2000 | $143,438 | | tax credit/rebate |
| ELI LILLY & COMPANY | Missouri | state | 2002 | $130,344 | | tax credit/rebate |
| ELI LILLY & COMPANY | Pennsylvania | state | 2020 | $96,100 | | tax credit/rebate |
| Eli Lilly | Indiana | multiple | 1999 | $214,000,000 | | MEGADEAL  |
| BOEHRINGER INGELHEIM VETMEDICA, INC. | Missouri | state | 2001 | $1,119,362 | | tax credit/rebate |
| BOEHRINGER INGELHEIM VETMEDICA, INC. | Missouri | state | 2011 | $740,939 | | tax credit/rebate |
| Boehringer Ingelheim Vetmedica, Inc. | Iowa | state | 2012 | $3,239,000 | | grant |
| Boehringer Ingelheim Vetmedica, Inc. | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
| Boehringer Ingelheim Vetmedica, Inc. | Iowa | state | 2010 | $5,275,484 | | tax credit/rebate |
| BOEHRINGER INGELHEIM VETMEDICA, INC. | Missouri | state | 2014 | $273,219 | | tax credit/rebate |
| Boehringer Ingelheim Vetmedica Inc. | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
| Boehringer Ingelheim Vetmedica Inc. | Iowa | state | 2015 | $516,584 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2008 | $101,627 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2009 | $123,461 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2010 | $48,077 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2011 | $159,381 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
| AVID Radiopharmaceuticals, Inc. | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
| Avid Radiopharmaceuticals, Inc. | Pennsylvania | state | 2006 | $100,000 | | tax credit/rebate |
| AVID RADIOPHARMACEUTICALS INC | Pennsylvania | state | 2020 | $9,000 | | tax credit/rebate |
| AVID Radiopharaceuticals, Inc. | Pennsylvania | state | 2007 | $100,000 | | tax credit/rebate |
| APPLIED MOLECULAR EVOLUTION INC | United States | federal | 2002 | $701,113 | | federal grant |
| APPLIED MOLECULAR EVOLUTION INC | United States | federal | 2001 | $329,770 | | federal grant |
